There are currently ten noteworthy regenerative medicine CMOs in operation in Japan. Most service providers focus on the PMD. Act route to market, but a few also provide services for those looking to enter the market under the ASRM route.
To find out more, fill out the form below.
Form 'FB_11822D12-5056-B731-4CE428726AACC48E' not found.